APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contraceptive Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Contraceptive Drugs Market Outlook and Growth Opportunities 2026

20 December 2025197 pages

Choose your research edition.

Industry ResearchOral Contraceptive Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contraceptive Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Oral Contraceptive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contraceptive Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contraceptive Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contraceptive Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Contraceptive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Contraceptive Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Contraceptive Drugs market include Teva Pharmaceutical, Johnson & Johnson, Baijingyu, Merck, Pfizer, Bayer, ZiZhu, Novo Nordisk A/S and Huazhong, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Contraceptive Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Contraceptive Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Contraceptive Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Contraceptive Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Contraceptive Drugs Segment by Company

Teva Pharmaceutical

Johnson & Johnson

Baijingyu

Merck

Pfizer

Bayer

ZiZhu

Novo Nordisk A/S

Huazhong

Gedeon Richter

Actavis

Oral Contraceptive Drugs Segment by Type

Short-acting Contraceptives

Emergency Contraceptives

Long-acting Contraceptives

Oral Contraceptive Drugs Segment by Application

Hospital

Pharmacy

Other

Oral Contraceptive Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Oral Contraceptive Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Contraceptive Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Contraceptive Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Contraceptive Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contraceptive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contraceptive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contraceptive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Contraceptive Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Contraceptive Drugs industry.

Chapter 3: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Contraceptive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Contraceptive Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Contraceptive Drugs Industry Trends Table 2. Oral Contraceptive Drugs Industry Drivers Table 3. Oral Contraceptive Drugs Industry Opportunities and Challenges Table 4. Oral Contraceptive Drugs Industry Restraints Table 5. Global Oral Contraceptive Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Contraceptive Drugs Revenue Share by Company (2021-2026) Table 7. Global Oral Contraceptive Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Oral Contraceptive Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Oral Contraceptive Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Oral Contraceptive Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Contraceptive Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Oral Contraceptive Drugs Company, Product Type & Application Table 13. Global Oral Contraceptive Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Contraceptive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Short-acting Contraceptives Table 18. Significant Companies of Emergency Contraceptives Table 19. Significant Companies of Long-acting Contraceptives Table 20. Global Oral Contraceptive Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Oral Contraceptive Drugs Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Oral Contraceptive Drugs Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Oral Contraceptive Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Oral Contraceptive Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Oral Contraceptive Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Oral Contraceptive Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Oral Contraceptive Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Oral Contraceptive Drugs Sales Value Share by Type (2021-2026) Table 29. Global Oral Contraceptive Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Other Table 33. Global Oral Contraceptive Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Oral Contraceptive Drugs Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Oral Contraceptive Drugs Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Oral Contraceptive Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Oral Contraceptive Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Oral Contraceptive Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Oral Contraceptive Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Oral Contraceptive Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Oral Contraceptive Drugs Sales Value Share by Application (2021-2026) Table 42. Global Oral Contraceptive Drugs Sales Value Share by Application (2027-2032) Table 43. Global Oral Contraceptive Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Oral Contraceptive Drugs Sales by Region (2021-2026) & (K Units) Table 45. Global Oral Contraceptive Drugs Sales Market Share by Region (2021-2026) Table 46. Global Oral Contraceptive Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Oral Contraceptive Drugs Sales Market Share by Region (2027-2032) Table 48. Global Oral Contraceptive Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Oral Contraceptive Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Oral Contraceptive Drugs Sales Value Share by Region (2021-2026) Table 51. Global Oral Contraceptive Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Oral Contraceptive Drugs Sales Value Share by Region (2027-2032) Table 53. Global Oral Contraceptive Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Oral Contraceptive Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Oral Contraceptive Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Oral Contraceptive Drugs Sales by Country (2021-2026) & (K Units) Table 58. Global Oral Contraceptive Drugs Sales Market Share by Country (2021-2026) Table 59. Global Oral Contraceptive Drugs Sales by Country (2027-2032) & (K Units) Table 60. Global Oral Contraceptive Drugs Sales Market Share by Country (2027-2032) Table 61. Global Oral Contraceptive Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Oral Contraceptive Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Oral Contraceptive Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Oral Contraceptive Drugs Sales Value Market Share by Country (2027-2032) Table 65. Teva Pharmaceutical Company Information Table 66. Teva Pharmaceutical Business Overview Table 67. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio Table 69. Teva Pharmaceutical Recent Development Table 70. Johnson & Johnson Company Information Table 71. Johnson & Johnson Business Overview Table 72. Johnson & Johnson Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Johnson & Johnson Oral Contraceptive Drugs Product Portfolio Table 74. Johnson & Johnson Recent Development Table 75. Baijingyu Company Information Table 76. Baijingyu Business Overview Table 77. Baijingyu Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Baijingyu Oral Contraceptive Drugs Product Portfolio Table 79. Baijingyu Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Merck Oral Contraceptive Drugs Product Portfolio Table 84. Merck Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Oral Contraceptive Drugs Product Portfolio Table 89. Pfizer Recent Development Table 90. Bayer Company Information Table 91. Bayer Business Overview Table 92. Bayer Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Bayer Oral Contraceptive Drugs Product Portfolio Table 94. Bayer Recent Development Table 95. ZiZhu Company Information Table 96. ZiZhu Business Overview Table 97. ZiZhu Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. ZiZhu Oral Contraceptive Drugs Product Portfolio Table 99. ZiZhu Recent Development Table 100. Novo Nordisk A/S Company Information Table 101. Novo Nordisk A/S Business Overview Table 102. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio Table 104. Novo Nordisk A/S Recent Development Table 105. Huazhong Company Information Table 106. Huazhong Business Overview Table 107. Huazhong Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Huazhong Oral Contraceptive Drugs Product Portfolio Table 109. Huazhong Recent Development Table 110. Gedeon Richter Company Information Table 111. Gedeon Richter Business Overview Table 112. Gedeon Richter Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Gedeon Richter Oral Contraceptive Drugs Product Portfolio Table 114. Gedeon Richter Recent Development Table 115. Actavis Company Information Table 116. Actavis Business Overview Table 117. Actavis Oral Contraceptive Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Actavis Oral Contraceptive Drugs Product Portfolio Table 119. Actavis Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Oral Contraceptive Drugs Distributors List Table 123. Oral Contraceptive Drugs Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Oral Contraceptive Drugs Product Image Figure 2. Global Oral Contraceptive Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Contraceptive Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Contraceptive Drugs Sales (2021-2032) & (K Units) Figure 5. Global Oral Contraceptive Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Oral Contraceptive Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Short-acting Contraceptives Image Figure 10. Emergency Contraceptives Image Figure 11. Long-acting Contraceptives Image Figure 12. Global Oral Contraceptive Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Oral Contraceptive Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Oral Contraceptive Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Oral Contraceptive Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Oral Contraceptive Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Oral Contraceptive Drugs Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Other Image Figure 21. Global Oral Contraceptive Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Oral Contraceptive Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Contraceptive Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Oral Contraceptive Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Oral Contraceptive Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Oral Contraceptive Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Oral Contraceptive Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Oral Contraceptive Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Oral Contraceptive Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Oral Contraceptive Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Oral Contraceptive Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Oral Contraceptive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Oral Contraceptive Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Oral Contraceptive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Oral Contraceptive Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Oral Contraceptive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Oral Contraceptive Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Oral Contraceptive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Oral Contraceptive Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Oral Contraceptive Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Oral Contraceptive Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Oral Contraceptive Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Short-acting Contraceptives
  • Emergency Contraceptives
  • Long-acting Contraceptives
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Baijingyu
  • Merck
  • Pfizer
  • Bayer
  • ZiZhu
  • Novo Nordisk A/S
  • Huazhong
  • Gedeon Richter
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Contraceptive Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Oral Contraceptive Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Contraceptive Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Contraceptive Drugs Market Dynamics
  1. 2.1 Oral Contraceptive Drugs Industry Trends
  2. 2.2 Oral Contraceptive Drugs Industry Drivers
  3. 2.3 Oral Contraceptive Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Contraceptive Drugs Industry Restraints
3 Oral Contraceptive Drugs Market by Company
  1. 3.1 Global Oral Contraceptive Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Oral Contraceptive Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Oral Contraceptive Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Contraceptive Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Oral Contraceptive Drugs Company Ranking (2024-2026)
  6. 3.6 Global Oral Contraceptive Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Contraceptive Drugs Company Product Type and Application
  8. 3.8 Global Oral Contraceptive Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Contraceptive Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Contraceptive Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Contraceptive Drugs Market by Type
  1. 4.1 Oral Contraceptive Drugs Type Introduction
  2. 4.1.1 Short-acting Contraceptives
  3. 4.1.2 Emergency Contraceptives
  4. 4.1.3 Long-acting Contraceptives
  5. 4.2 Global Oral Contraceptive Drugs Sales Volume by Type
  6. 4.2.1 Global Oral Contraceptive Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Oral Contraceptive Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Oral Contraceptive Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Oral Contraceptive Drugs Sales Value by Type
  10. 4.3.1 Global Oral Contraceptive Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Oral Contraceptive Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Oral Contraceptive Drugs Sales Value Share by Type (2021-2032)
5 Oral Contraceptive Drugs Market by Application
  1. 5.1 Oral Contraceptive Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Oral Contraceptive Drugs Sales Volume by Application
  6. 5.2.1 Global Oral Contraceptive Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Contraceptive Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Oral Contraceptive Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Oral Contraceptive Drugs Sales Value by Application
  10. 5.3.1 Global Oral Contraceptive Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Oral Contraceptive Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Oral Contraceptive Drugs Sales Value Share by Application (2021-2032)
6 Oral Contraceptive Drugs Regional Sales and Value Analysis
  1. 6.1 Global Oral Contraceptive Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Contraceptive Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Contraceptive Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Contraceptive Drugs Sales by Region (2027-2032)
  5. 6.3 Global Oral Contraceptive Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Contraceptive Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Contraceptive Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Contraceptive Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Contraceptive Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Contraceptive Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Oral Contraceptive Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Contraceptive Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Contraceptive Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Contraceptive Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Contraceptive Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Contraceptive Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Oral Contraceptive Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Contraceptive Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Contraceptive Drugs Sales Value Share by Country, 2025 VS 2032
7 Oral Contraceptive Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Oral Contraceptive Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Contraceptive Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Contraceptive Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Contraceptive Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Contraceptive Drugs Sales by Country (2027-2032)
  6. 7.4 Global Oral Contraceptive Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Contraceptive Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Contraceptive Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Contraceptive Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Contraceptive Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Contraceptive Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Oral Contraceptive Drugs Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Baijingyu
  14. 8.3.1 Baijingyu Company Information
  15. 8.3.2 Baijingyu Business Overview
  16. 8.3.3 Baijingyu Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Baijingyu Oral Contraceptive Drugs Product Portfolio
  18. 8.3.5 Baijingyu Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Oral Contraceptive Drugs Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Oral Contraceptive Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Oral Contraceptive Drugs Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 ZiZhu
  38. 8.7.1 ZiZhu Company Information
  39. 8.7.2 ZiZhu Business Overview
  40. 8.7.3 ZiZhu Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ZiZhu Oral Contraceptive Drugs Product Portfolio
  42. 8.7.5 ZiZhu Recent Developments
  43. 8.8 Novo Nordisk A/S
  44. 8.8.1 Novo Nordisk A/S Company Information
  45. 8.8.2 Novo Nordisk A/S Business Overview
  46. 8.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio
  48. 8.8.5 Novo Nordisk A/S Recent Developments
  49. 8.9 Huazhong
  50. 8.9.1 Huazhong Company Information
  51. 8.9.2 Huazhong Business Overview
  52. 8.9.3 Huazhong Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huazhong Oral Contraceptive Drugs Product Portfolio
  54. 8.9.5 Huazhong Recent Developments
  55. 8.10 Gedeon Richter
  56. 8.10.1 Gedeon Richter Company Information
  57. 8.10.2 Gedeon Richter Business Overview
  58. 8.10.3 Gedeon Richter Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Gedeon Richter Oral Contraceptive Drugs Product Portfolio
  60. 8.10.5 Gedeon Richter Recent Developments
  61. 8.11 Actavis
  62. 8.11.1 Actavis Company Information
  63. 8.11.2 Actavis Business Overview
  64. 8.11.3 Actavis Oral Contraceptive Drugs Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Actavis Oral Contraceptive Drugs Product Portfolio
  66. 8.11.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Contraceptive Drugs Value Chain Analysis
  2. 9.1.1 Oral Contraceptive Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Contraceptive Drugs Sales Mode & Process
  6. 9.2 Oral Contraceptive Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Contraceptive Drugs Distributors
  9. 9.2.3 Oral Contraceptive Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst